Skip to search formSkip to main contentSkip to account menu

Pancreatic Neoplasm

Known as: Neoplasia of the pancreas, Neoplasm, Pancreatic, Tumor of Pancreas 
Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from… 
National Institutes of Health

Related topics

Related topics

40 relations
1 ML Octreotide 0.1 MG/ML InjectionBlood supply aspectsDoxorubicin HydrochlorideExocrine pancreas

Narrower (10)

Bilateral pheochromocytoma and islet cell adenoma of the pancreasGastro-enteropancreatic neuroendocrine tumorMalignant neoplasm of pancreasNon functioning pancreatic endocrine tumor

Broader (3)

Digestive System NeoplasmsEndocrine Gland NeoplasmsPancreatic Diseases

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
The Tumor Suppressor Gene WWOX at FRA16D Is Involved in Pancreatic Carcinogenesis
Purpose: WWOX (WW domain containing oxidoreductase) is a tumor suppressor gene that maps to the common fragile site FRA16D. We… 
Highly Cited
1999
Highly Cited
1999
Association of increased immunostaining for inducible nitric oxide synthase and nitrotyrosine with fibroblast growth factor transformation in pancreatic cancer.
BACKGROUND Despite recognition of the devastating malignant potential of pancreatic cancer, the exact pathophysiological events… 
Highly Cited
1999
Highly Cited
1999
Radiotherapy and dosimetry of 64Cu-TETA-Tyr3-octreotate in a somatostatin receptor-positive, tumor-bearing rat model.
64Cu [T1/2 = 12.8 h; beta+ = 0.655 MeV (19%); beta- = 0.573 MeV (40%)] has shown promise as a radioisotope for targeted… 
Highly Cited
1997
Highly Cited
1997
Sensitization of colorectal and pancreatic cancer cell lines to the prodrug 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954) by retroviral transduction and expression of the E. coli nitroreductase…
Expression of genes encoding prodrug-activating enzymes can increase the susceptibility of tumor cells to prodrugs, and may… 
Review
1996
Review
1996
Frequent codeletion of p16/MTS1 and p15/MTS2 and genetic alterations in p16/MTS1 in pancreatic tumors.
BACKGROUND & AIMS Cell-cycle inhibitor and tumor-suppressor gene p16/MTS1 was found to be altered in a variety of human tumors… 
Highly Cited
1993
Highly Cited
1993
Mucin-producing tumor of the pancreas: natural history and serial pancreatogram changes.
The clinical features and changes of the pancreatic duct system in nine patients with mucin-producing tumor of the pancreas were… 
Highly Cited
1990
Highly Cited
1990
Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing
Ras gene is one of the oncegenes most commonly detected in human cancers and consists of three families (H‐ras, K‐ras, N‐ras… 
Highly Cited
1984
Highly Cited
1984
Reversed-phase high-performance liquid chromatography: preparative purification of synthetic peptides.
Highly Cited
1983
Highly Cited
1983
EFFECTS OF HUMAN PANCREATIC TUMOUR GROWTH HORMONE RELEASING FACTOR ON GROWTH HORMONE AND SOMATOMEDIN C LEVELS IN PATIENTS WITH IDIOPATHIC GROWTH HORMONE DEFICIENCY
Highly Cited
1981
Highly Cited
1981
Current knowledge of pancreatic carcinogenesis in the hamster and its relevance to the human disease
Syrian hamsters present a unique species for induction of pancreatic tumors that in many aspects resemble human pancreatic cancer… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)